23andMe Holding Co. (NASDAQ:ME) Q4 2022 Earnings Conference Call May 26, 2022 4:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Kenneth Hillan - Chief Therapeutics Officer Steve Schoch - Chief Financial Officer Conference Call Participants Tiago Fauth - Credit Suisse AG Daniel Grosslight - Citigroup Inc. Operator Good morning, and welcome to the 23andMe's Fiscal Year 2022 Fourth Quarter and Year-End Financial Results Conf ...